NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-0.28%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$7.68B
AUM Growth
+$7.68B
Cap. Flow
+$3.58B
Cap. Flow %
46.59%
Top 10 Hldgs %
77.12%
Holding
65
New
7
Increased
1
Reduced
7
Closed
2

Sector Composition

1 Healthcare 79.17%
2 Consumer Staples 8.56%
3 Technology 5.15%
4 Industrials 3.37%
5 Financials 1.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GRTX
26
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$42.9M 0.56%
4,362,986
BDTX icon
27
Black Diamond Therapeutics
BDTX
$157M
$42.1M 0.55%
3,449,845
INZY
28
DELISTED
Inozyme Pharma
INZY
$41.7M 0.54%
2,444,379
SVRA icon
29
Savara
SVRA
$567M
$41M 0.53%
24,137,931
AFMD
30
DELISTED
Affimed
AFMD
$37.6M 0.49%
4,426,488
-978,774
-18% -$8.32M
UPST icon
31
Upstart Holdings
UPST
$7.05B
$35.9M 0.47%
287,092
-286,092
-50% -$35.7M
BE icon
32
Bloom Energy
BE
$12.4B
$35.8M 0.47%
1,333,333
VRNA
33
Verona Pharma
VRNA
$9.16B
$33.4M 0.44%
5,108,563
ELVN icon
34
Enliven Therapeutics
ELVN
$1.2B
$31.7M 0.41%
4,017,170
MRKR icon
35
Marker Therapeutics
MRKR
$12M
$29.9M 0.39%
10,714,285
AVEO
36
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$26.1M 0.34%
3,952,958
PHAS
37
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$24.7M 0.32%
6,643,704
MEIP icon
38
MEI Pharma
MEIP
$160M
$24.3M 0.32%
8,533,072
GNCA
39
DELISTED
Genocea Biosciences, Inc.
GNCA
$24.3M 0.32%
10,376,936
STSA
40
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$22.2M 0.29%
3,142,958
+145,276
+5% +$1.02M
CBIO
41
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$21.1M 0.27%
9,089,041
GERN icon
42
Geron
GERN
$893M
$19M 0.25%
13,461,538
XENE icon
43
Xenon Pharmaceuticals
XENE
$2.98B
$18.5M 0.24%
992,107
CTIC
44
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$17.9M 0.23%
7,140,450
CSBR icon
45
Champions Oncology
CSBR
$93.8M
$17.6M 0.23%
1,713,720
ADXN
46
Addex Therapeutics
ADXN
$17.2M 0.22%
+180,000
New +$17.2M
SYBX icon
47
Synlogic
SYBX
$17M
$16.5M 0.21%
4,229,410
IVA
48
Inventiva
IVA
$861M
$14.2M 0.19%
1,041,666
OBSV
49
DELISTED
ObsEva SA Ordinary Shares
OBSV
$13.9M 0.18%
4,586,563
TRVI icon
50
Trevi Therapeutics
TRVI
$883M
$13.4M 0.17%
5,940,796